Stay up-to-date with the latest developments in securities law through access to both news and all statutes and regulations. Find relevant corporate filings through a searchable EDGAR database. And...
The SEC sued an attorney and three others over their alleged roles in a $34 million international scheme to manipulate the stock of medical firm Biozoom Inc.
Vancouver-based attorney Faiyaz Dean, Francisco Abellan Villena, Guillermo Ciupiak, and James B. Panther Jr. “played an integral role” in the scheme, according to a May 15 Securities and Exchange Commission complaint in the U.S. District Court for the Southern District of New York..
Abellan and Ciupiak allegedly masterminded the fraud. Panther created accounts, facilitated Biozoom stock trading, and created a campaign to promote the scheme, according to the complaint. Dean allegedly purchased stock for Abellan and Ciupiak while disguising their control over it. He also helped Panther create brokerage accounts, the complaint said.
The four defendants allegedly “hid their ownership and sales of Biozoom shares by using offshore bank accounts, sham legal documents, a network of nominees, anonymizing techniques, and other deceptive practices,” the SEC said in a statement.
Panther “intends to defend himself against the allegations in the SEC complaint,” Russell Duncan, his attorney, told Bloomberg Law. Duncan is based in Potomac, Md., and chair of Shulman Rogers Gandal Pordy & Ecker P.A.'s White Collar, Securities Enforcement, and Government Investigations group.
“My office is reviewing the complaint and has no comment at this time,” Michael Bachner, Dean’s New York-based attorney, told Bloomberg Law.
Attorneys for Villena and Ciupiak couldn’t be identified for comment.
The defendants used shell companies to artificially drive up demand for Biozoom stock, according to the complaint. Dean allegedly hid Abellan and Ciupiak’s ownership of a shell company by putting the shares in the names of Argentine nationals who didn’t have any actual economic interest in the stock. He also falsified documents to hide the fact that the shares couldn’t be freely resold, the complaint said.
“Manipulative and deceptive conduct undermines the integrity of our markets,” Antonia Chion, an SEC Enforcement Division associate director, said in a statement. “The charges announced today demonstrate our commitment to unraveling even the most sophisticated international schemes that exploit retail investors.”
Two related SEC administrative actions settled May 15. Timothy Scarpino agreed to bars on participating in penny stock offerings and associating with broker-dealers for his role in unregistered Biozoom stock sales. Mark A. Karow and Legend Securities Inc. agreed to similar bars, a censure, and about $94,000 in disgorgement and fines for unregistered sales and supervisory and recordkeeping failures. In settling, the defendants neither admitted nor denied wrongdoing.
The SEC in 2013 received a court order freezing proceeds from the unlawful sales of Biozoom stock. The agency then got a default judgment and has to date returned $14 million to investors. The SEC in 2017 sued and later barred a different attorney for helping Biozoom’s predecessor entity with the fraud.
The case is SEC v. Villena , S.D.N.Y., No. 1:18-cv-04309, complaint filed 5/15/18 .
To contact the reporter on this story: Jennifer Bennett in Washington at email@example.com
To contact the editor responsible for this story: Seth Stern at firstname.lastname@example.org
Copyright © 2018 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)